Zytiga
For mCSPC, Abiraterone Plus ADT and Docetaxel Improves rPFS
In men with de novo metastatic castration-sensitive prostate cancer, the addition of abiraterone (Zytiga, Janssen) ...
SEPTEMBER 2, 2021
Abiraterone + ADT Shows Strong Benefits in Prostate Cancer Trials
Chicago—In patients with newly diagnosed advanced prostate cancer, initiating abiraterone at the same time as ...
JULY 6, 2017
Load more